![](https://image.cnbcfm.com/api/v1/image/107261721-1687535078142-gettyimages-1302141463-cailly04.jpeg?v=1698881162)
Eli Lilly effects most sensible estimates on Mounjaro energy however slashes full-year benefit outlook
Eli Lilly reported third-quarter income and changed profits that crowned expectancies, lifted by way of $1.4 billion in gross sales from its blockbuster diabetes drug Mounjaro. However the corporate slashed its full-year benefit